Bora CDMO Bora CDMO

X

List of NDC API details of Erlotinib Hydrochloride Active Pharmaceutical Ingredient listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

Flag Canada
Digital Content Digital Content
URL Supplier Web Content
Erlotinib HCl
POWDER (1g/g)
BULK INGREDIENT FOR ...
73377-225
2023-03-21
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Erlotinib hydrochloride
POWDER (1g/g)
BULK INGREDIENT FOR ...
73309-141
2020-06-09
2023-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
Erlotinib HCl
POWDER (1kg/kg)
BULK INGREDIENT
59116-4251
2014-06-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
Erlotinib HCl
POWDER (1kg/kg)
BULK INGREDIENT
59116-4250
2014-03-25
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER (25kg/25kg)
BULK INGREDIENT
53104-7716
2016-01-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
59997-0003
2014-11-12
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
ERLOTINIB HYDROCHLORIDE
POWDER (1kg/kg)
BULK INGREDIENT
48087-0133
2022-09-14
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Erlotinib
POWDER (1kg/kg)
BULK INGREDIENT
68554-0052
2004-11-18
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
54893-0012
2012-05-26
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride (Form-B)
POWDER (1kg/kg)
BULK INGREDIENT
54893-0067
2017-12-29
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Erlotinib
POWDER (1kg/kg)
BULK INGREDIENT
63850-7566
2016-01-21
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
82920-021
2022-08-11
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER, FOR SUSPENSION (1kg/kg)
BULK INGREDIENT FOR ...
61200-013
2015-05-14
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Mexico
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER (100kg/100kg)
BULK INGREDIENT
63592-3407
2018-11-05
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Mexico
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER (100kg/100kg)
BULK INGREDIENT
63592-3400
2018-11-05
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

VALARY LAB LIMITED

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
Erlotinib Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
81955-0010
2004-11-08
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 100MG BASE
  • TABLET;ORAL - EQ 150MG BASE
  • TABLET;ORAL - EQ 25MG BASE

Looking for 183319-69-9 / Erlotinib Hydrochloride API manufacturers, exporters & distributors?

Erlotinib Hydrochloride manufacturers, exporters & distributors 1

22

PharmaCompass offers a list of Erlotinib Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Erlotinib Hydrochloride manufacturer or Erlotinib Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Erlotinib Hydrochloride manufacturer or Erlotinib Hydrochloride supplier.

PharmaCompass also assists you with knowing the Erlotinib Hydrochloride API Price utilized in the formulation of products. Erlotinib Hydrochloride API Price is not always fixed or binding as the Erlotinib Hydrochloride Price is obtained through a variety of data sources. The Erlotinib Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Erlotinib Hydrochloride

Synonyms

183319-69-9, Erlotinib hcl, Tarceva, Osi-774, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride, Osi 774

Cas Number

183319-69-9

Unique Ingredient Identifier (UNII)

DA87705X9K

About Erlotinib Hydrochloride

A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.

Erlotinib Hydrochloride Manufacturers

A Erlotinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Erlotinib Hydrochloride, including repackagers and relabelers. The FDA regulates Erlotinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Erlotinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Erlotinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Erlotinib Hydrochloride Suppliers

A Erlotinib Hydrochloride supplier is an individual or a company that provides Erlotinib Hydrochloride active pharmaceutical ingredient (API) or Erlotinib Hydrochloride finished formulations upon request. The Erlotinib Hydrochloride suppliers may include Erlotinib Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Erlotinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Erlotinib Hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Erlotinib Hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Erlotinib Hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Erlotinib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Erlotinib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Erlotinib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Erlotinib Hydrochloride suppliers with NDC on PharmaCompass.

Erlotinib Hydrochloride Manufacturers | Traders | Suppliers

Erlotinib Hydrochloride Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY